Skip to main content
    C

    Celularity Inc (CELU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.56
    -0.05 (-8.85%)

    Market Cap: $20.45M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Celularity Inc (CELU) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Celularity (CELU) has a market cap of $20.45M. It kept -269.61% of revenue as net income over the last 12 months. Revenue fell 63.02% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$20.45M
    Latest price (Nov 17, 2026)$0.56

    Key Dates

    Last Earnings DateOct 20, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 3.15% in the quarter ended Sep 30, 2026 and grew 15.55% a year over 2 years.

    Shares Outstanding29.34M
    Shares Change (YoY)+11.37%
    Shares Change (QoQ)-3.15%
    Share Count Growth (2Y CAGR)+15.55%

    Price Statistics

    The stock is down 63.59% over 52 weeks and trades 50.88% below its 50-day average.

    Beta (1Y)1.94
    52-Week Change-63.59%
    1-Month Change-51.35%
    3-Month Change-27.47%
    6-Month Change-30.00%
    5-Year Change-98.81%
    Total Return (1Y)-63.59%
    Total Return (3Y CAGR)-35.44%
    Total Return (5Y CAGR)-61.82%
    Max Drawdown (1Y)-73.13%
    Max Drawdown (3Y)-91.89%
    Sharpe Ratio (1Y)-0.86
    Correlation with SPY (1Y)0.20
    50-Day Average$1.14
    200-Day Average$1.05
    52-Week Range$0.56 to $2.55
    RSI (14 Days)29.8
    Average Volume (20 Days)187.96K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.11x current liabilities.

    Current Ratio0.11x
    Quick Ratio0.10x
    Interest Coverage-19.29x

    Returns and Efficiency

    Return on Assets (ROA)-95.37%
    Return on Capital Employed (ROCE)-123.02%
    ROA (5Y Average)-57.23%
    ROIC (5Y Average)83.21%
    Asset Turnover0.17x
    Inventory Turnover31.04x
    Receivables Turnover3.70x
    Cash Conversion Cycle-280 days

    Scores

    CELU has an Altman Z-Score of -16.36, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score-16.36
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $17.49M over the last 12 months.

    Revenue$17.49M
    Revenue Growth (YoY)-63.02%
    Gross Profit-$1.06M
    Operating Income-$58.49M
    Pretax Income-$47.14M
    Net Income-$47.14M
    EBITDA-$38.07M
    EBIT-$44.81M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$586.00K
    Working Capital-$53.29M
    Shareholder Equity-$35.53M
    Tangible Book Value-$49.21M
    Total Assets$96.17M
    Total Liabilities$131.70M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $0 of capital spending, operating cash flow left -$9.87M of free cash flow.

    Operating Cash Flow-$9.87M
    Capital Expenditures$0
    Free Cash Flow-$9.87M
    FCF Per Share-$0.30
    Depreciation and Amortization$6.74M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -334.47%.

    Gross Margin-6.07%
    Operating Margin-334.47%
    Pretax Margin-269.58%
    Net Margin-269.61%
    EBITDA Margin-217.73%
    EBIT Margin-256.29%
    FCF Margin-56.43%
    Gross Margin (5Y Average)34.35%

    Growth

    Revenue grew 13.88% a year over 3 years.

    Revenue Growth (3Y CAGR)+13.88%
    Revenue Growth (5Y CAGR)+13.21%

    Revenue and profit by year

    Dividends and Yields

    CELU does not pay a dividend. Its free cash flow yield is -59.59%.

    FCF Yield-59.59%
    Shareholder Yield0.91%

    Stock Splits

    The last split was a 1-for-10 reverse split on Feb 29, 2024.

    Last Split DateFeb 29, 2024
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 3 similar companies, CELU has the lowest P/S.

    P/S Ratio0.9x vs 16.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)-63.02% vs -93.31% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CELU

    What is CELU's market cap?

    Celularity has a market cap of $20.45M.

    How many shares of CELU are outstanding?

    Celularity has 29.34M shares outstanding. The count is up 11.37% from a year earlier.

    Does CELU pay a dividend?

    No. Celularity does not pay a dividend.